Translating Tobacco Addiction Research to Treatment

The summary for the Translating Tobacco Addiction Research to Treatment grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Translating Tobacco Addiction Research to Treatment: The National Institute on Drug Abuse (NIDA) is committed to the translation of research findings into practice. The purpose of this initiative is to support research designed to translate existing knowledge about the targets, mechanisms and processes of nicotine addiction into treatments immediately applicable or demonstrably exportable to the treatment of tobacco addiction in humans. It is envisioned that the research will be conducted using laboratory studies with human volunteers, or Stage I style clinical studies. However, it is possible that basic research studies may be relevant to the objective of this RFA and, as such, may be one logical component of the work plan of an application. For example, studies with animal models might be relevant to the discovery of more details regarding the mode of action of a clinically used medication, knowledge that, in turn, would allow development of more specific medications. For such applications the applicant will need to provide a compelling rational that the basic research, if successful will, in fact, have direct impact on clinical research, with direct application to treatment interventions. Notwithstanding the importance of the further discovery of the targets, mechanisms and processes of drug addiction, such research itself is not the focus of this RFA. The purpose of this announcement is to foster research that translates existing knowledge into treatment and treatment practice, or research that, in and of itself, will readily translate to clinical research or practice.